7-hydroxystaurosporine has been researched along with Cancer of Cervix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosset, M; Decrion-Barthod, AZ; Launay, S; Marchini, A; Mougin, C; Nicolier, M; Plissonnier, ML; Prétet, JL; Rommelaere, J | 1 |
| Alfieri, AA; Sommers, GM | 1 |
2 other study(ies) available for 7-hydroxystaurosporine and Cancer of Cervix
| Article | Year |
|---|---|
Sodium butyrate with UCN-01 has marked antitumour activity against cervical cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Butyrates; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Female; HeLa Cells; Human papillomavirus 16; Human papillomavirus 18; Humans; Mice; Mice, Nude; Papillomavirus Infections; Staurosporine; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2010 |
Multimodality therapy: radiation and continuous concomitant cis-platinum and PKC inhibition in a cervical carcinoma model.
Topics: Alkaloids; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Enzyme Inhibitors; Female; HeLa Cells; Humans; Protein Kinase C; Radiotherapy Dosage; Spheroids, Cellular; Staurosporine; Tumor Stem Cell Assay; Uterine Cervical Neoplasms | 1998 |